These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias]. Ohnishi S, Kasanuki H. J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174 [Abstract] [Full Text] [Related]
3. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A. G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218 [Abstract] [Full Text] [Related]
4. [Antiarrhythmic agents in the prevention of sudden cardiac death]. Halawa B. Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592 [Abstract] [Full Text] [Related]
6. Current approaches to evaluation and management of patients with ventricular arrhythmias. Buxton AE, Kirk MM, Michaud GF. Med Health R I; 2001 Feb; 84(2):58-62. PubMed ID: 11272662 [Abstract] [Full Text] [Related]
7. Ventricular arrhythmias: medical therapy, device treatment, and indications for electrophysiologic study. Sager PT, Batsford WP. Cardiol Clin; 1988 Feb; 6(1):37-47. PubMed ID: 3048673 [Abstract] [Full Text] [Related]
8. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated]. Alboni P. Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849 [Abstract] [Full Text] [Related]
9. [Arrhythmia risk stratification based on etiological and anatomo-structural factors]. Disertori M, Dallafior D, Marini M. Ital Heart J Suppl; 2001 Dec; 2(12):1265-9. PubMed ID: 11838346 [Abstract] [Full Text] [Related]
10. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects]. Gronda E, Mangiavacchi M, Andreuzzi B, Municinò A. Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348 [Abstract] [Full Text] [Related]
14. [Antiarrhythmia agents in heart failure]. Duc P. Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):595-8. PubMed ID: 7487307 [Abstract] [Full Text] [Related]
15. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery. Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A. G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124 [Abstract] [Full Text] [Related]
16. [Predictive factors of induction of ventricular arrhythmia under amiodarone]. Bourret N, Kirkorian G, Chevalier P, Bellon C, Richalet C, Bouchayer D, Bonnefoy E, Touboul P. Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1277-81. PubMed ID: 8952825 [Abstract] [Full Text] [Related]
17. Ventricular arrhythmias. Kavanagh KM, Wyse DG. CMAJ; 1988 May 15; 138(10):903-13. PubMed ID: 3284626 [Abstract] [Full Text] [Related]
18. Ventricular arrhythmias during left ventricular assist device support. Bedi M, Kormos R, Winowich S, McNamara DM, Mathier MA, Murali S. Am J Cardiol; 2007 Apr 15; 99(8):1151-3. PubMed ID: 17437746 [Abstract] [Full Text] [Related]
19. Pharmacologic therapy in patients with ventricular tachyarrhythmias. Wyse DG. Cardiol Clin; 1993 Feb 15; 11(1):65-83. PubMed ID: 8435825 [Abstract] [Full Text] [Related]